Antidepressant Effects of Aripiprazole Augmentation for Cilostazol-Treated Mice Exposed to Chronic Mild Stress after Ischemic Stroke
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q1
- 저널
- INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES18(2) · 2017
- 피인용
- Web of Science 13
- JCR IF
- JCR 2016 3.226
- ISSN
- 1661-6596
저자
- 김유리제1저자Department of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan, South Korea
- 김하늬Department of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan, South Korea
- 홍기환Department of Pharmacology, School of Medicine, Pusan National University, Yangsan, South Korea
- 신화경Department of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan, South Korea
- 최병태교신저자Department of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan, South Korea
초록
The aim of this study was to determine the effects and underlying mechanism of aripiprazole (APZ) augmentation for cilostazol (CLS)-treated post-ischemic stroke mice that were exposed to chronic mild stress (CMS). Compared to treatment with either APZ or CLS alone, the combined treatment resulted in a greater reduction in depressive behaviors, including anhedonia, despair-like behaviors, and memory impairments. This treatment also significantly reduced atrophic changes in the striatum, cortex, and midbrain of CMS-treated ischemic mice, and inhibited neuronal cell apoptosis, particularly in the striatum and the dentate gyrus of the hippocampus. Greater proliferation of neuronal progenitor cells was also observed in the ipsilateral striatum of the mice receiving combined treatment compared to mice receiving either drug alone. Phosphorylation of the cyclic adenosine monophosphate response element binding protein (CREB) was increased in the striatum, hippocampus, and midbrain of mice receiving combined treatment compared to treatment with either drug alone, particularly in the neurons of the striatum and hippocampus, and dopaminergic neurons of the midbrain. Our results suggest that APZ may augment the antidepressant effects of CLS via co-regulation of the CREB signaling pathway, resulting in the synergistic enhancement of their neuroprotective effects.
키워드
aripiprazolecilostazoldepressionstrokechronic mild stressCHRONIC CEREBRAL HYPOPERFUSIONELEMENT-BINDING PROTEINLATE-LIFE DEPRESSIONPOSTSTROKE DEPRESSIONDENTATE GYRUSCOGNITIVE FUNCTIONSFACTOR EXPRESSIONBRAIN-INJURYMOUSE MODELKAPPA-B
식별자
- WoS UID
- 000395457700123



로그인
연구물 목록으로